Randomized phase III trial of 2 nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer : short-term versus prolonged treatment

Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99] P. Albers*, S.-I. Park, G. Niegisch, G. Fechner, U. Steiner, J. Lehmann, D. Heimbach, A. Heidenreich, R. Fimmers & R. Siener for the AUO Bladder Cancer Group Department of Urology, Düsseldorf University, Düsseldorf; Department of Urology, Bonn University, Bonn; Department of Urology, Charité University Berlin, Berlin; Department of Urology, Homburg University, Homburg; Department of Urology, St. Vincenz Hospital, Datteln; Department of Urology, Aachen University, Aachen; Institute of Medical Biometry, Informatics and Epidemiology, Bonn University, Bonn, Germany